The population structure in most European countries is currently changing, with a shift from younger to older age groups. Only sparse data exist on the impact of these demographic changes on future blood demand and supply. Data on blood recipients are sparse and unconnected to data on blood donors. The first part of this review summarizes studies on the effect of the demographic change on blood supply and demand. With respect to studies in North America and Europe on the impact of demographic changes on future blood supply, the demographic trends will affect many regions in the Western world similarly. These effects are most pronounced in the new member states of the European Union where birth rates declined abruptly after 1989. Coordinated efforts will be required to prevent blood shortages based upon these demographic trends in Western societies. The second part of this review is an overview of methodological approaches to obtain data on the sociodemographic background of the blood donor population.

Keywords:
Donor research, Blood supply, Demography
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.